Canadian cannabis companies seek European investment ahead of October 17.
Cannabis executives predict a European market boom in the next three years.
Organigram invests €4.4 million in European hemp and CBD producer Eviana.
Invictus seeks EU-GMP Certification after raising €17.4 million in funding.
GW Pharma plans to sell €260 million of American depositary shares.
Cannabis beverages could be a €521 million market in the US by 2022.
Queensland opens its first medical cannabis clinic.
AusCann’s Chilean subsidiary signsan MoU with Khiron Life Sciences.
Canadian cannabis companies are using Latin America as global export centre.
France’s ANSM announces members of the special committee on medical cannabis.
European Parliament's committee approves initial motion on medical cannabis.
An update on Denmark’s new medical cannabis pilot programmes.
Civil society groups push Thai government to legalise medical cannabis.
Guam Senate debates a bill allowing patients to cultivate medical cannabis.
US FDA recommends that CBD be descheduled.
You can now look back on every issue of European Cannabis Weekly and read the stories that have helped shape the European cannabis industry over the past year.
Click here to catch up on any stories you may have missed.